# Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy

> **NCT02689778** · PHASE3 · COMPLETED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 62 (actual)

## Conditions studied

- Diabetic Nephropathy
- Albuminuria

## Interventions

- **DRUG:** Pirfenidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02689778
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689778, "Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02689778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*